ACE2 and Innate Immunity in the Regulation of SARS-CoV-2-Induced Acute Lung Injury: A Review

Código QR

ACE2 and Innate Immunity in the Regulation of SARS-CoV-2-Induced Acute Lung Injury: A Review

Despite the protracted battle against coronavirus acute respiratory infection (COVID-19) and the rapid evolution of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), no specific and effective drugs have to date been reported. Angiotensin-converting enzyme 2 (ACE2) is a zinc metallopr...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Lihua Qu, Chao Chen, Tong Yin, Qian Fang, Zizhan Hong, Rui Zhou, Hongbin Tang, Huifen Dong
Formato:	article
Lenguaje:	EN
Publicado:	MDPI AG 2021
Materias:	ACE2 immune cells COVID-19 SARS-CoV-2 ALI Biology (General) QH301-705.5 Chemistry QD1-999
Acceso en línea:	https://doaj.org/article/f3eb507a47094bab8b3cde90601693e3
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Killing Two Birds with One Stone by Administration of Soluble ACE2: A Promising Strategy to Treat Both Cardiovascular Diseases and SARS-CoV-2 Infection
por: Fengling Feng, et al.
Publicado: (2021)

Presencia y Expresión del Receptor ACE2 (Target de SARS-CoV-2) en Tejidos Humanos y Cavidad Oral. Posibles Rutas de Infección en Órganos Orales
por: Pastrian-Soto,Gabriel
Publicado: (2020)

Antiviral Activity of Type I, II, and III Interferons Counterbalances ACE2 Inducibility and Restricts SARS-CoV-2
por: Idoia Busnadiego, et al.
Publicado: (2020)

Measurement of serum ACE status may potentially improve the diagnosis of SARS-CoV-2 infection
por: Gcinokwakhe D Ngcobo
Publicado: (2021)

Potencial Afectación de las Glándulas Salivales en la Infección por SARS-CoV-2 (COVID-19)
por: Melián-Rivas,Andrés, et al.
Publicado: (2021)

Recombinant ACE2 Expression Is Required for SARS-CoV-2 To Infect Primary Human Endothelial Cells and Induce Inflammatory and Procoagulative Responses
por: Jonas Nascimento Conde, et al.
Publicado: (2020)

Dinamika Interaksi Reseptor ACE2 dan SARS-CoV-2 Terhadap Manifestasi Klinis COVID-19
por: Risma Ikawaty
Publicado: (2020)

Codon usage, phylogeny and binding energy estimation predict the evolution of SARS-CoV-2
por: Matteo Calcagnile, et al.
Publicado: (2021)

PDZ-Containing Proteins Targeted by the ACE2 Receptor
por: Célia Caillet-Saguy, et al.
Publicado: (2021)

A Collection of Designed Peptides to Target SARS-CoV-2 Spike RBD—ACE2 Interaction
por: Narcis Fernandez-Fuentes, et al.
Publicado: (2021)

Comparison of SARS-CoV-2 Receptors Expression in Primary Endothelial Cells and Retinoic Acid-Differentiated Human Neuronal Cells
por: Francesca Benedetti, et al.
Publicado: (2021)

ACE2 enzymatic role in the SARS-CoV-2 activation: a perspective through the evolutionary promiscuity and substrate diversity of enzymes
por: Angela Madalina Lazar
Publicado: (2021)

Effects of common mutations in the SARS-CoV-2 Spike RBD and its ligand, the human ACE2 receptor on binding affinity and kinetics
por: Michael I Barton, et al.
Publicado: (2021)

SARS-CoV-2: Overview and Its Impact on Oral Health
por: Miriam Ting, et al.
Publicado: (2021)

Evidence of SARS-CoV-2 Transmission Through the Ocular Route
por: Qu JY, et al.
Publicado: (2021)

The Role of the Ocular Tissue in SARS-CoV-2 Transmission
por: Peng M, et al.
Publicado: (2020)

Stapled Peptides Based on Human Angiotensin-Converting Enzyme 2 (ACE2) Potently Inhibit SARS-CoV-2 Infection <italic toggle="yes">In Vitro</italic>
por: Francesca Curreli, et al.
Publicado: (2020)

Compromiso neurológico en infección por COVID-19 en pacientes pediátricos
por: Quiroz S.,Vicente, et al.
Publicado: (2020)

Effect of Angiotensin-Converting-Enzyme Inhibitor and Angiotensin II Receptor Antagonist Treatment on ACE2 Expression and SARS-CoV-2 Replication in Primary Airway Epithelial Cells
por: Oghenemega Okoloko, et al.
Publicado: (2021)

Common Laboratory Mice Are Susceptible to Infection with the SARS-CoV-2 Beta Variant
por: Ravi Kant, et al.
Publicado: (2021)

A Plausible Link of TMPRSS2/ACE2/AR Signaling to Male Mortality during the COVID-19 Pandemic in the United States
por: Lilly M. Wong, et al.
Publicado: (2021)

OTRO DESAFIO DE LA NATURALEZA: EL NUEVO CORONAVIRUS VIROLOGÍA Y FISIOPATOLOGÍA DEL SARS-COV-2
por: Gema Pérez A, et al.
Publicado: (2020)

Association between angiotensinogen (AGT), angiotensin-converting enzyme (ACE) and angiotensin-II receptor 1 (AGTR1) polymorphisms and COVID-19 infection in the southeast of Iran: a preliminary case-control study
por: Hamid Reza Kouhpayeh, et al.
Publicado: (2021)

Repurposing benzimidazole and benzothiazole derivatives as potential inhibitors of SARS-CoV-2: DFT, QSAR, molecular docking, molecular dynamics simulation, and in-silico pharmacokinetic and toxicity studies
por: Ranjan K. Mohapatra, et al.
Publicado: (2021)

La Saliva como Biomuestra para Diagnóstico de Infección por SARS-CoV-2: Una Revisión
por: Morales-Espinosa,Rolando
Publicado: (2020)

SARS-CoV-2 and Human Immunodeficiency Virus: Pathogen Pincer Attack
por: Evans N, et al.
Publicado: (2021)

Rapid Assessment of Binding Affinity of SARS-COV-2 Spike Protein to the Human Angiotensin-Converting Enzyme 2 Receptor and to Neutralizing Biomolecules Based on Computer Simulations
por: Damiano Buratto, et al.
Publicado: (2021)

The Renin-Angiotensin System: A Key Role in SARS-CoV-2-Induced COVID-19
por: George El-Arif, et al.
Publicado: (2021)

Strong Association of Angiotensin Converting Enzyme-2 Gene Insertion/Deletion Polymorphism with Susceptibility to SARS-CoV-2, Hypertension, Coronary Artery Disease and COVID-19 Disease Mortality
por: Mohammad Muzaffar Mir, et al.
Publicado: (2021)

An Update on Animal Models for Severe Acute Respiratory Syndrome Coronavirus 2 Infection and Countermeasure Development
por: Liang Zhang, et al.
Publicado: (2021)

Can Science Help Resolve the Controversy on the Origins of the SARS-CoV-2 Pandemic?
por: Arturo Casadevall, et al.
Publicado: (2021)

Weekly SARS-CoV-2 screening of asymptomatic kindergarten to grade 12 students and staff helps inform strategies for safer in-person learning
por: Shira Doron, et al.
Publicado: (2021)

Postmortem Stability of SARS-CoV-2 in Mouse Lung Tissue
por: Sophie A. Valkenburg, et al.
Publicado: (2021)

Pandemia SARS-CoV-2 y embarazo en el Hospital el Pino: un estudio descriptivo
por: Morales M.,Nereida, et al.
Publicado: (2020)

Effective Prophylaxis of COVID-19 in Rhesus Macaques Using a Combination of Two Parenterally-Administered SARS-CoV-2 Neutralizing Antibodies
por: Brandon J. Beddingfield, et al.
Publicado: (2021)

CLÍNICA Y DIAGNÓSTICO SARS-COV-2
por: María Ester Pizarro
Publicado: (2020)

Assessment of COVID-19 Incidence and the Ability to Synthesise Anti-SARS-CoV-2 Antibodies of Paediatric Patients with Primary Immunodeficiency
por: Karolina Pieniawska-Śmiech, et al.
Publicado: (2021)

Can the SARS-CoV-2 Spike Protein Bind Integrins Independent of the RGD Sequence?
por: Christopher A. Beaudoin, et al.
Publicado: (2021)

In silico Identification of Characteristics Spike Glycoprotein of SARS-CoV-2 in the Development Novel Candidates for COVID-19 Infectious Diseases
por: Taufik Muhammad Fakih, et al.
Publicado: (2020)

The TMPRSS2 Inhibitor Nafamostat Reduces SARS-CoV-2 Pulmonary Infection in Mouse Models of COVID-19
por: Kun Li, et al.
Publicado: (2021)